Safety and efficacy of Enoxaparine sodium after oncogynecological surgical patients:phase 2 study

Phase 2

• Conditions: gynecological cancer

• Registration Number: JPRN-UMIN000003246
• Lead Sponsor: Kansai clinical oncology group

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-03-01
• Study Completion: 2012-03-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

bleeder etc

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
incidence of bleeding event

Secondary Outcome Measures

Name	Time	Method
incidence of venous thromboembolism